Intercure Ltd (INCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Intercure Ltd Stock (INCR) Company Profile

Intercure Ltd

Healthcare (1188)

Prossima data di guadagno

Ultimi documenti SEC

INCR's Discussions on Twitter

Confronta INCR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INCR Intercure Ltd	1.6166	72.77M	118.18M	5.99M	-12.91M	0.1319
ZTS Zoetis Inc	163.90	73.51B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.515	43.13B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.27	41.98B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	22.07	24.97B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	12.53	14.86B	15.05B	-883.30M	1.89B	-0.74

Intercure Ltd Stock (INCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-05-18	Aggiornamento	Canaccord Genuity	Speculative Buy → Buy

Intercure Ltd Borsa (INCR) Ultime notizie

Intercure Ltd Azioni (INCR) Dati Finanziari

Intercure Ltd (INCR)

Intercure Ltd Stock (INCR) Company Profile

Confronta INCR con altri titoli

Intercure Ltd Stock (INCR) Upgrades & Downgrades

Intercure Ltd Borsa (INCR) Ultime notizie

Cannabis co InterCure raising NIS 66m for Nir Oz facility - Globes

InterCure secures $18.2M for post-war recovery By Investing.com - Investing.com Australia

InterCure secures $18.2M for post-war recovery - Investing.com

InterCure Secures Major Funding to Boost Growth - TipRanks

InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - Nasdaq

Reviewing InterCure (NASDAQ:INCR) & NeuroBo Pharmaceuticals (NASDAQ:NRBO) - Defense World

InterCure Ltd. (NASDAQ:INCR) Short Interest Update - MarketBeat

InterCure Ltd. (NASDAQ:INCR) Sees Significant Drop in Short Interest - MarketBeat

InterCure Ltd. (NASDAQ:INCR) Sees Large Decline in Short Interest - MarketBeat

Synbiotic's CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure - Business of Cannabis -

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive

InterCure Ltd. (NASDAQ:INCR) Sees Significant Increase in Short Interest - MarketBeat

Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany - Benzinga

InterCure nears break even in first half of 2024, despite ongoing Israel-Hamas war - Green Market Report

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewswire

InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com

InterCure partners with Cookies to launch cannabis pharmacies in Germany By Investing.com - Investing.com Australia

InterCure partners with Cookies to launch cannabis pharmacies in Germany - Investing.com

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Business Wire

InterCure (NASDAQ:INCR) Stock Price Up 0.5% - MarketBeat

Tidal Investments LLC Invests $883,000 in InterCure Ltd. (NASDAQ:INCR) - American Banking and Market News

Cannabis News: Majority of Americans Want Rescheduling or Legalization; European Market Growth Could be Game-Changer; Spotlight on InterCure - Market Research Record

Support for Regulatory Changes Surrounding Cannabis Remains Strong in the US, Companies Like InterCure Could Also Benefit From Growth in Europe - Markets Herald

Mirae Asset Global Investments Co. Ltd. Sells 467,995 Shares of InterCure Ltd. (NASDAQ:INCR) - Defense World

InterCure Ltd. (NASDAQ:INCR) Stake Cut by Mirae Asset Global Investments Co. Ltd. - MarketBeat

InterCure (NASDAQ:INCR) Shares Up 1% - MarketBeat

InterCure (NASDAQ:INCR) Trading 1% Higher - Defense World

IM Cannabis Merger Scrapped, Cel AI Gets a New CEO, & More from Intercure - Business of Cannabis -

Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ - Benzinga

Analyst: Israel’s InterCure paving path to big gains - Green Market Report

InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference - Yahoo Finance

InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion - Benzinga

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million - Business Wire

InterCure: Bargain Israel Cannabis Play (NASDAQ:INCR) - Seeking Alpha

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million - Yahoo Finance

symbol__ Stock Quote Price and Forecast - CNN

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint - Business Wire

InterCure Provides Update Regarding Nir Oz Facility in Israel - Cannabis Business Times

InterCure Provides an Update Regarding Nir Oz Facility - GlobeNewswire

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain - GlobeNewswire

Israeli Cannabis Firms Navigate Challenges Amid Hamas Conflict, Cellular Goods Signs New Joint Venture, & More from SEED Innovations - Business of Cannabis -

InterCure Provides an Update Regarding the Security Situation in Israel - Financial Post

Israeli Cannabis Adjusts to War - Green Market Report

Celadon Announces New £1.2m Supply Deal, Intercure Continues Record Run, & Chill Brands Launches Products in UK - Business of Cannabis -

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY - GlobeNewswire

InterCure: Leader In Israel's Growing Medical Cannabis Market (NASDAQ:INCR) - Seeking Alpha

InterCure Decides to Leave Toronto Stock Exchange - Green Market Report

InterCure Ltd. Announces Proposed Voluntary Delisting from - GlobeNewswire

Intercure Counter-Sued By Better, Cantourage Sees Stock Jump 30%, & Tikun Olam Cannbit To Be Acquired - Business of Cannabis -

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY - GlobeNewswire

Intercure Ltd Azioni (INCR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a INCR